Rocket Drew

Source: The Information Anthropic released Claude Science on Tuesday, a new desktop application to assist biologists with research by writing code, literature reviews and research reports, drawing on databases of biology research and biology-focused AI models. Anthropic has also decided to start running its own drug programs in pre-clinical stages, which are the early parts of drug discovery, focusing on neglected diseases.

Tech leaders from Elon Musk and Jensen Huang to a slew of startup founders and their venture-capitalist backers say robotics is headed for a “ChatGPT moment” where AI enables a wide range of physical world tasks. But the industry is increasingly split on how to get there. At issue is which kind of AI models are most promising for powering robots.

Last week, Anthropic boasted that Claude is now writing 80% of Anthropic’s code, which the company presented as a harbinger of a critical leap in artificial intelligence called recursive self-improvement. That’s when models are so capable that they can create the next generation of AI without human involvement. Excitement about recursive self-improvement seems to be in the air in Silicon Valley.